Hong Kong Construction Stock News

SEHK:3696
SEHK:3696Life Sciences

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After Strong Year To Date Share Price Gains

Setting the scene for InSilico Medicine Cayman TopCo InSilico Medicine Cayman TopCo (SEHK:3696) has drawn fresh attention after recent share price moves, with a 1 day return of about 1.6% and a 7 day gain of roughly 4.7%. See our latest analysis for InSilico Medicine Cayman TopCo. The latest moves sit within a much stronger trend, with a year to date share price return of about 58.9% at a current share price of roughly HK$59.7. This suggests momentum has been building as investors reassess...
SEHK:1913
SEHK:1913Luxury

Assessing Prada’s Valuation After Recent Share Price Weakness And Perceived Intrinsic Discount

Why Prada’s Recent Share Performance May Have Your Attention Prada (SEHK:1913) has caught investor attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, alongside a negative 1 year total return. See our latest analysis for Prada. At a share price of HK$41.18, Prada’s recent 30 day share price return of 9.61% decline and 1 year total shareholder return of 32.25% decline suggest momentum has been fading over...
SEHK:1164
SEHK:1164Oil and Gas

What Does CGN Mining’s 2025 Uranium Output Reveal About Its Long-Term Scale? (SEHK:1164)

CGN Mining Company Limited recently reported its unaudited natural uranium production results, recording 702.5 tU for the fourth quarter and 2,699.0 tU for full year 2025. This production update offers investors a clearer view of CGN Mining’s operational scale in natural uranium, helping frame expectations around future output capacity. We will now examine how CGN Mining’s full-year 2025 uranium production scale shapes the company’s broader investment narrative. Outshine the giants: these 23...